logo

For the Inventor, By the Inventor

Fremont, CA, United States of America

Saul Jaime-Figueroa

This inventor holds 11 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Roche Palo Alto LLC, Syntex (u.s.a.) Inc., Syntex LLC. Active years: 1999-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saul Jaime-Figueroa. Retrieved from https://idiyas.com/inventor/saul-jaime-figueroa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 54.5


Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 125(Granted Patents)


Company Filing History:

goldMedal6 out of 322 
 
Roche Palo Alto LLC
 patents
silverMedal4 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
bronzeMedal1 out of 47 
 
Syntex LLC
 patents

Years Active: 1999-2017

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 9670151 - Tetralin and indane derivatives and uses thereof (2017-06-06),
2. 8889906 - Tetralin and indane derivatives and uses thereof (2014-11-18),
3. 8093424 - Tetralin and indane derivatives and uses thereof (2012-01-10),
4. 7863305 - 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors (2011-01-04),
5. 7638517 - 3-Amino-1-arylpropyl azaindoles and uses thereof (2009-12-29),
6. 7312359 - Tetralin and indane derivatives and uses thereof (2007-12-25),
7. 6852726 - Substituted indoles as alpha-1 agonists (2005-02-08),
8. 5958934 - Aryl pyrimidine derivatives and uses thereof (1999-09-28),
9. 5952331 - Aryl pyrimidine derivatives (1999-09-14),
10. 5863924 - Aryl pyrimidine derivatives (1999-01-26),
11. 5859014 - Pyrimidinedione, pyrimidinetrione, triazinedione and (1999-01-12),

Title: The Innovative Contributions of Saul Jaime-Figueroa

Introduction: Saul Jaime-Figueroa is a prominent inventor based in Fremont, California. With a remarkable track record of 11 patents, he has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds.

Latest Patents: Among his latest innovations are patents pertaining to tetralin and indane derivatives. These patents detail compounds of the formula I, including pharmaceutically acceptable salts, wherein specific elements such as m, p, q, Ar, R, and R are meticulously defined. The patents also provide comprehensive methods for preparing these compounds, compositions that include them, and techniques for utilizing the compounds effectively in pharmaceutical applications.

Career Highlights: Saul has had an impressive career, working with reputable companies such as Roche Palo Alto LLC and Syntex (U.S.A.) Inc. His work has advanced the understanding and application of complex chemical compounds, contributing to the development of new medicinal treatments.

Collaborations: Throughout his career, Saul has collaborated with notable colleagues, including Robert J. Greenhouse and Ralph New Harris, III. These partnerships have likely enriched his research and innovation processes, fostering a dynamic environment for creativity and development in the pharmaceutical sciences.

Conclusion: Saul Jaime-Figueroa's work exemplifies the impact that dedicated inventors can have within the pharmaceutical industry. His 11 patents underscore a commitment to innovation and provide a solid foundation for advancements in drug development, highlighting the importance of collaboration and research in achieving success.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…